BackAntares Pharma Overview

Antares Pharma Other Assets

Track Antares Pharma's other assets ($1.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$1.20M
↓ 51.88% YoYΔ $-1.30M vs prior year quarter

Peer trimmed avg / median

Loading

Antares Pharma Other Assets History

Loading

Antares Pharma vs. peers: Other Assets Comparison

Loading

Antares Pharma Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Antares Pharma (ATRS) FAQ

The latest other assets for ATRS is $1.2M as of March 2022. That compares with $2.5M in the prior-year period — down 51.9% year over year. Investors often review this figure alongside Antares Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, ATRS's other assets moved from $2.5M to $1.2M — a 51.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Antares Pharma's operating scale or balance-sheet position.

A other assets figure of $1.2M for ATRS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ATRS's other assets ($1.2M), review year-over-year change from $2.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Antares Pharma's other assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.